INSIGHTS ICD Registry

Completed

Conditions studied: Ventricular Tachycardia, Ventricular Fibrillation

In brief

The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

Key facts

Study ID

NCT00279968

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

1326

Starts

2004-02-01

Expected to finish

2006-01-01

Last updated by the study team

2007-12-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years of age or older.
• Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
• New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.

You may not qualify if…

• Patients enrolled in a device study which effects programming and or treatment.

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — Fountain Valley, California, United States
• Study site — Poway, California, United States
• Study site — Sacramento, California, United States
• Study site — Santa Ana, California, United States
• Study site — Boulder, Colorado, United States
• Study site — Bradenton, Florida, United States
• Study site — Lakeland, Florida, United States
• Study site — Lauderdale Lakes, Florida, United States
• Study site — Palm Beach Gardens, Florida, United States
• Study site — Panama City, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Gainesville, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Crown Point, Indiana, United States
• Study site — Noblesville, Indiana, United States
• Study site — Monroe, Louisiana, United States
• Study site — Annapolis, Maryland, United States
• Study site — Glen Burnie, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Detroit, Michigan, United States
• Study site — Kalamazoo, Michigan, United States
• Study site — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.